CN Stock MarketDetailed Quotes

688468 Chemclin Diagnostics Co., Ltd.

Watchlist
  • 5.70
  • -0.14-2.40%
Market Closed Sep 6 15:00 CST
2.29BMarket Cap15.53P/E (TTM)

Chemclin Diagnostics Co., Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
2.91%225.59M
10.36%111.39M
-4.28%445.34M
-4.07%345.27M
-1.93%219.22M
-16.50%100.93M
-1.17%465.27M
1.25%359.92M
-5.66%223.53M
0.55%120.88M
Operating revenue
2.91%225.59M
10.36%111.39M
-4.28%445.34M
-4.07%345.27M
-1.93%219.22M
-16.50%100.93M
-1.17%465.27M
1.25%359.92M
-5.66%223.53M
0.55%120.88M
Total operating cost
-1.55%147.91M
10.54%74.16M
-5.00%306.9M
-7.68%227.46M
-3.76%150.25M
-17.03%67.08M
-1.30%323.04M
0.89%246.39M
-2.26%156.11M
4.94%80.85M
Operating cost
-5.92%51.48M
0.70%24.78M
-7.99%109.72M
-7.64%85.18M
-6.03%54.71M
-19.26%24.61M
0.74%119.26M
5.16%92.22M
2.37%58.23M
3.63%30.48M
Operating tax surcharges
-1.60%2.63M
-3.72%1.19M
-2.57%5.35M
-1.63%4.19M
-1.90%2.68M
-15.82%1.24M
49.93%5.49M
71.07%4.26M
82.38%2.73M
73.17%1.47M
Operating expense
-5.94%41.29M
12.69%19.43M
-2.52%92.27M
-9.61%65.76M
-6.10%43.9M
-25.08%17.25M
-9.33%94.66M
-8.85%72.75M
-10.82%46.75M
-4.06%23.02M
Administration expense
30.33%26.15M
43.87%11.8M
1.34%40.51M
-0.67%29.83M
6.88%20.06M
-4.76%8.2M
4.40%39.98M
-0.22%30.03M
-4.13%18.77M
2.37%8.61M
Financial expense
-14.06%-3.28M
-28.23%-1.67M
-28.55%-6.74M
-12.58%-4.73M
-5.02%-2.88M
-5.66%-1.3M
-9.89%-5.24M
-2.33%-4.2M
-28.87%-2.74M
-255.25%-1.23M
-Interest expense (Financial expense)
706.51%1.08M
257.57%274.83K
-9.00%472.01K
-59.58%170.48K
-56.21%133.48K
-58.28%76.86K
-28.95%518.69K
-23.79%421.73K
-17.76%304.81K
6.50%184.22K
-Interest Income (Financial expense)
-50.17%-4.39M
-34.35%-1.95M
-33.51%-7.27M
-16.06%-4.89M
-1.36%-2.93M
-0.65%-1.45M
4.25%-5.45M
11.64%-4.21M
-14.57%-2.89M
-179.38%-1.45M
Research and development
-6.68%29.65M
8.93%18.62M
-4.54%65.77M
-7.99%47.24M
-1.87%31.78M
-7.64%17.09M
2.34%68.89M
6.41%51.34M
2.85%32.38M
25.63%18.5M
Credit Impairment Loss
-87.16%37.18K
40.04%181.11K
1,759.17%413.64K
95.25%255.72K
47.69%289.43K
30.42%129.33K
95.02%-24.93K
286.93%130.97K
159.44%195.97K
154.24%99.16K
Asset Impairment Loss
22.08%-1.27M
90.82%-8.39K
-9.83%-3.63M
-15.11%-2.09M
-38.58%-1.62M
-5.63%-91.4K
-86.64%-3.31M
-35.09%-1.81M
-90.11%-1.17M
52.77%-86.52K
Other net revenue
Invest income
-27.80%7.06M
-0.78%4.23M
-24.57%14.77M
-20.60%12.19M
-4.85%9.78M
-8.01%4.26M
55.38%19.58M
123.24%15.35M
157.68%10.28M
234.72%4.64M
Asset deal income
1,339.39%235.14K
7,061.12%214.51K
149.16%177.88K
214.78%118.16K
162.42%16.34K
105.94%3K
171.39%71.39K
200.53%37.54K
-140.21%-26.17K
---50.41K
Other revenue
-85.35%1.2M
1.89%762.45K
37.19%16.11M
22.15%8.23M
12,320.30%8.2M
1,033.71%748.34K
32.46%11.74M
-0.60%6.74M
-87.23%66.01K
-76.87%66.01K
Operating profit
-0.80%84.95M
9.54%42.62M
-2.35%166.29M
1.90%136.51M
11.56%85.63M
-12.96%38.9M
4.74%170.29M
8.52%133.97M
-5.03%76.76M
0.50%44.69M
Add:Non operating Income
123.50%201.94K
811.69%82.64K
-98.70%103.43K
-97.26%98.64K
-97.47%90.35K
-97.76%9.06K
1,838.00%7.95M
786.04%3.6M
2,932.41%3.57M
5,223.59%404.48K
Less:Non operating expense
526.57%457.53K
477.54%414.69K
-69.10%269.81K
-66.24%264.94K
-82.08%73.02K
-57.46%71.8K
8.97%873.15K
38.41%784.83K
18.02%407.59K
97.46%168.79K
Total profit
-1.12%84.69M
8.86%42.28M
-6.34%166.12M
-0.32%136.34M
7.17%85.65M
-13.55%38.84M
9.36%177.37M
10.95%136.78M
-0.83%79.92M
1.21%44.93M
Less:Income tax cost
-10.77%8.05M
-2.82%3.89M
-24.23%18.75M
-13.11%16.1M
-13.30%9.02M
-31.23%4M
27.32%24.74M
19.73%18.53M
-1.66%10.4M
-6.91%5.82M
Net profit
0.01%76.64M
10.21%38.39M
-3.44%147.37M
1.68%120.24M
10.23%76.63M
-10.92%34.84M
6.91%152.63M
9.69%118.25M
-0.71%69.52M
2.54%39.11M
Net profit from continuing operation
0.01%76.64M
10.21%38.39M
-3.44%147.37M
1.68%120.24M
10.23%76.63M
-10.92%34.84M
6.91%152.63M
9.69%118.25M
-0.71%69.52M
2.54%39.11M
Net profit of parent company owners
0.01%76.64M
10.21%38.39M
-3.44%147.37M
1.68%120.24M
10.23%76.63M
-10.92%34.84M
6.91%152.63M
9.69%118.25M
-0.71%69.52M
2.54%39.11M
Earning per share
Basic earning per share
0.00%0.19
11.11%0.1
-2.63%0.37
3.45%0.3
11.76%0.19
-10.00%0.09
2.70%0.38
3.57%0.29
-10.53%0.17
-9.09%0.1
Diluted earning per share
0.00%0.19
11.11%0.1
-2.63%0.37
3.45%0.3
11.76%0.19
-10.00%0.09
2.70%0.38
3.57%0.29
-10.53%0.17
-9.09%0.1
Other composite income
Total composite income
0.01%76.64M
10.21%38.39M
-3.44%147.37M
1.68%120.24M
10.23%76.63M
-10.92%34.84M
6.91%152.63M
9.69%118.25M
-0.71%69.52M
2.54%39.11M
Total composite income of parent company owners
0.01%76.64M
10.21%38.39M
-3.44%147.37M
1.68%120.24M
10.23%76.63M
-10.92%34.84M
6.91%152.63M
9.69%118.25M
-0.71%69.52M
2.54%39.11M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 2.91%225.59M10.36%111.39M-4.28%445.34M-4.07%345.27M-1.93%219.22M-16.50%100.93M-1.17%465.27M1.25%359.92M-5.66%223.53M0.55%120.88M
Operating revenue 2.91%225.59M10.36%111.39M-4.28%445.34M-4.07%345.27M-1.93%219.22M-16.50%100.93M-1.17%465.27M1.25%359.92M-5.66%223.53M0.55%120.88M
Total operating cost -1.55%147.91M10.54%74.16M-5.00%306.9M-7.68%227.46M-3.76%150.25M-17.03%67.08M-1.30%323.04M0.89%246.39M-2.26%156.11M4.94%80.85M
Operating cost -5.92%51.48M0.70%24.78M-7.99%109.72M-7.64%85.18M-6.03%54.71M-19.26%24.61M0.74%119.26M5.16%92.22M2.37%58.23M3.63%30.48M
Operating tax surcharges -1.60%2.63M-3.72%1.19M-2.57%5.35M-1.63%4.19M-1.90%2.68M-15.82%1.24M49.93%5.49M71.07%4.26M82.38%2.73M73.17%1.47M
Operating expense -5.94%41.29M12.69%19.43M-2.52%92.27M-9.61%65.76M-6.10%43.9M-25.08%17.25M-9.33%94.66M-8.85%72.75M-10.82%46.75M-4.06%23.02M
Administration expense 30.33%26.15M43.87%11.8M1.34%40.51M-0.67%29.83M6.88%20.06M-4.76%8.2M4.40%39.98M-0.22%30.03M-4.13%18.77M2.37%8.61M
Financial expense -14.06%-3.28M-28.23%-1.67M-28.55%-6.74M-12.58%-4.73M-5.02%-2.88M-5.66%-1.3M-9.89%-5.24M-2.33%-4.2M-28.87%-2.74M-255.25%-1.23M
-Interest expense (Financial expense) 706.51%1.08M257.57%274.83K-9.00%472.01K-59.58%170.48K-56.21%133.48K-58.28%76.86K-28.95%518.69K-23.79%421.73K-17.76%304.81K6.50%184.22K
-Interest Income (Financial expense) -50.17%-4.39M-34.35%-1.95M-33.51%-7.27M-16.06%-4.89M-1.36%-2.93M-0.65%-1.45M4.25%-5.45M11.64%-4.21M-14.57%-2.89M-179.38%-1.45M
Research and development -6.68%29.65M8.93%18.62M-4.54%65.77M-7.99%47.24M-1.87%31.78M-7.64%17.09M2.34%68.89M6.41%51.34M2.85%32.38M25.63%18.5M
Credit Impairment Loss -87.16%37.18K40.04%181.11K1,759.17%413.64K95.25%255.72K47.69%289.43K30.42%129.33K95.02%-24.93K286.93%130.97K159.44%195.97K154.24%99.16K
Asset Impairment Loss 22.08%-1.27M90.82%-8.39K-9.83%-3.63M-15.11%-2.09M-38.58%-1.62M-5.63%-91.4K-86.64%-3.31M-35.09%-1.81M-90.11%-1.17M52.77%-86.52K
Other net revenue
Invest income -27.80%7.06M-0.78%4.23M-24.57%14.77M-20.60%12.19M-4.85%9.78M-8.01%4.26M55.38%19.58M123.24%15.35M157.68%10.28M234.72%4.64M
Asset deal income 1,339.39%235.14K7,061.12%214.51K149.16%177.88K214.78%118.16K162.42%16.34K105.94%3K171.39%71.39K200.53%37.54K-140.21%-26.17K---50.41K
Other revenue -85.35%1.2M1.89%762.45K37.19%16.11M22.15%8.23M12,320.30%8.2M1,033.71%748.34K32.46%11.74M-0.60%6.74M-87.23%66.01K-76.87%66.01K
Operating profit -0.80%84.95M9.54%42.62M-2.35%166.29M1.90%136.51M11.56%85.63M-12.96%38.9M4.74%170.29M8.52%133.97M-5.03%76.76M0.50%44.69M
Add:Non operating Income 123.50%201.94K811.69%82.64K-98.70%103.43K-97.26%98.64K-97.47%90.35K-97.76%9.06K1,838.00%7.95M786.04%3.6M2,932.41%3.57M5,223.59%404.48K
Less:Non operating expense 526.57%457.53K477.54%414.69K-69.10%269.81K-66.24%264.94K-82.08%73.02K-57.46%71.8K8.97%873.15K38.41%784.83K18.02%407.59K97.46%168.79K
Total profit -1.12%84.69M8.86%42.28M-6.34%166.12M-0.32%136.34M7.17%85.65M-13.55%38.84M9.36%177.37M10.95%136.78M-0.83%79.92M1.21%44.93M
Less:Income tax cost -10.77%8.05M-2.82%3.89M-24.23%18.75M-13.11%16.1M-13.30%9.02M-31.23%4M27.32%24.74M19.73%18.53M-1.66%10.4M-6.91%5.82M
Net profit 0.01%76.64M10.21%38.39M-3.44%147.37M1.68%120.24M10.23%76.63M-10.92%34.84M6.91%152.63M9.69%118.25M-0.71%69.52M2.54%39.11M
Net profit from continuing operation 0.01%76.64M10.21%38.39M-3.44%147.37M1.68%120.24M10.23%76.63M-10.92%34.84M6.91%152.63M9.69%118.25M-0.71%69.52M2.54%39.11M
Net profit of parent company owners 0.01%76.64M10.21%38.39M-3.44%147.37M1.68%120.24M10.23%76.63M-10.92%34.84M6.91%152.63M9.69%118.25M-0.71%69.52M2.54%39.11M
Earning per share
Basic earning per share 0.00%0.1911.11%0.1-2.63%0.373.45%0.311.76%0.19-10.00%0.092.70%0.383.57%0.29-10.53%0.17-9.09%0.1
Diluted earning per share 0.00%0.1911.11%0.1-2.63%0.373.45%0.311.76%0.19-10.00%0.092.70%0.383.57%0.29-10.53%0.17-9.09%0.1
Other composite income
Total composite income 0.01%76.64M10.21%38.39M-3.44%147.37M1.68%120.24M10.23%76.63M-10.92%34.84M6.91%152.63M9.69%118.25M-0.71%69.52M2.54%39.11M
Total composite income of parent company owners 0.01%76.64M10.21%38.39M-3.44%147.37M1.68%120.24M10.23%76.63M-10.92%34.84M6.91%152.63M9.69%118.25M-0.71%69.52M2.54%39.11M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------Shinnaganaka & Chung Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg